PL1502590T3 - Pochodne oksymów heterocyklicznych, ich sposób wytwarzania i ich zastosowanie w leczeniu cukrzycy typu II - Google Patents

Pochodne oksymów heterocyklicznych, ich sposób wytwarzania i ich zastosowanie w leczeniu cukrzycy typu II

Info

Publication number: PL1502590T3
Authority: PL; Poland
Prior art keywords: diabetes; preparation; treatment; type; oxime derivatives
Prior art date: 2003-07-28

Application number

PL04291901T

Other languages

English (en)

Inventor

Véronique Leclerc

Sylvie Pailloux

Pascal Carato

Carine Introvigne

Nicolas Lebegue

Pascal Berthelot

Catherine Dacquet

Jean Albert Boutin

Daniel Henri Caignard

Pierre Renard

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-28

Filing date

2004-07-27

Publication date

2007-04-30

2004-07-27 Application filed by Servier Lab filed Critical Servier Lab

2007-04-30 Publication of PL1502590T3 publication Critical patent/PL1502590T3/pl

Links

-1 Heterocyclic oxime Chemical class 0.000 title 1
238000000034 method Methods 0.000 title 1
208000001072 type 2 diabetes mellitus Diseases 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Child & Adolescent Psychology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

PL04291901T 2003-07-28 2004-07-27 Pochodne oksymów heterocyklicznych, ich sposób wytwarzania i ich zastosowanie w leczeniu cukrzycy typu II PL1502590T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0309214A FR2858321B1 (fr)	2003-07-28	2003-07-28	Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP04291901A EP1502590B1 (fr)	2003-07-28	2004-07-27	Dérivés d'oximes hétérocycliques, leur procédé de préparation et leur utilisation dans le traitement du diabète de type II

Publications (1)

Publication Number	Publication Date
PL1502590T3 true PL1502590T3 (pl)	2007-04-30

Family

ID=33523001

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04291901T PL1502590T3 (pl)	2003-07-28	2004-07-27	Pochodne oksymów heterocyklicznych, ich sposób wytwarzania i ich zastosowanie w leczeniu cukrzycy typu II

Country Status (30)

Country	Link
US (1)	US7071221B2 (pl)
EP (1)	EP1502590B1 (pl)
JP (1)	JP4406331B2 (pl)
KR (1)	KR100677013B1 (pl)
CN (1)	CN100497323C (pl)
AR (1)	AR045125A1 (pl)
AT (1)	ATE348612T1 (pl)
AU (1)	AU2004203454B2 (pl)
BR (1)	BRPI0403028A (pl)
CA (1)	CA2475137C (pl)
CY (1)	CY1106336T1 (pl)
DE (1)	DE602004003751T2 (pl)
DK (1)	DK1502590T3 (pl)
EA (1)	EA007718B1 (pl)
EG (1)	EG24967A (pl)
ES (1)	ES2279310T3 (pl)
FR (1)	FR2858321B1 (pl)
GE (1)	GEP20063896B (pl)
HR (1)	HRP20070117T8 (pl)
MA (1)	MA27104A1 (pl)
MX (1)	MXPA04007257A (pl)
MY (1)	MY139278A (pl)
NO (1)	NO327257B1 (pl)
NZ (1)	NZ534334A (pl)
PL (1)	PL1502590T3 (pl)
PT (1)	PT1502590E (pl)
SG (1)	SG109010A1 (pl)
SI (1)	SI1502590T1 (pl)
UA (1)	UA80814C2 (pl)
ZA (1)	ZA200405893B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2009516730A (ja) *	2005-11-23	2009-04-23	アストラゼネカアクチボラグ	Ｌ−アラニン誘導体
FR2894965B1 (fr) *	2005-12-20	2008-01-25	Servier Lab	Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2898125B1 (fr) *	2006-03-06	2008-06-13	Servier Lab	Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20080045521A1 (en) *	2006-06-09	2008-02-21	Astrazeneca Ab	Phenylalanine derivatives
FR2903404B1 (fr) *	2006-07-10	2008-08-22	Servier Lab	Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20090062267A1 (en) *	2007-01-29	2009-03-05	Astrazeneca Ab	L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS
WO2008125811A1 (en) *	2007-04-11	2008-10-23	Astrazeneca Ab	N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
US9193767B2 (en)	2011-03-30	2015-11-24	Brown University	Enopeptins, uses thereof, and methods of synthesis thereto
WO2016037072A2 (en) *	2014-09-04	2016-03-10	Brown University	Enopeptin analogas and methods of use thereof
CN104725367B (zh) *	2015-03-13	2017-06-23	三峡大学	四氢苯并噻唑‑7‑酮肟药物，制备方法及其应用
CN104788436B (zh) *	2015-03-13	2018-05-01	三峡大学	四氢苯并呋喃-4-酮肟基三唑药物，制备方法及其应用
US10604520B2 (en) *	2016-09-07	2020-03-31	Pliant Therapeutics, Inc.	N-acyl amino acid compounds and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US32769A (en) *		1861-07-09		Beehive
US4228292A (en) *	1978-07-20	1980-10-14	Monsanto Company	N-Substituted benzothiazolines and benzoxazolines and their use as herbicides and plant growth regulants
EP0022317B1 (en) *	1979-06-12	1983-09-21	Fujisawa Pharmaceutical Co., Ltd.	2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives
CZ283339B6 (cs) *	1993-09-15	1998-03-18	Sankyo Company Limited	Použití thiazolidinových derivátů pro výrobu léčivého přípravku pro léčení zhoršené tolerance glukosy pro zabránění nebo zpoždění nástupu diabetes mellitus nezávislé na inzulinu
SK111195A3 (en) *	1994-09-13	1997-06-04	Sandoz Technology Ltd	Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
FR2804431A1 (fr) *	2000-02-02	2001-08-03	Adir	Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1440383A (zh) *	2000-04-28	2003-09-03	三共株式会社	PPARγ调制剂
FR2830012B1 (fr) *	2001-09-21	2003-10-31	Servier Lab	Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharamaceutiques qui les contiennent

2003
- 2003-07-28 FR FR0309214A patent/FR2858321B1/fr not_active Expired - Fee Related
2004
- 2004-07-20 CA CA2475137A patent/CA2475137C/fr not_active Expired - Fee Related
- 2004-07-21 SG SG200404504A patent/SG109010A1/en unknown
- 2004-07-23 ZA ZA200405893A patent/ZA200405893B/xx unknown
- 2004-07-26 MY MYPI20042999A patent/MY139278A/en unknown
- 2004-07-27 AT AT04291901T patent/ATE348612T1/de active
- 2004-07-27 ES ES04291901T patent/ES2279310T3/es not_active Expired - Lifetime
- 2004-07-27 PL PL04291901T patent/PL1502590T3/pl unknown
- 2004-07-27 UA UA20040706233A patent/UA80814C2/xx unknown
- 2004-07-27 BR BR0403028-1A patent/BRPI0403028A/pt not_active IP Right Cessation
- 2004-07-27 GE GE5664A patent/GEP20063896B/en unknown
- 2004-07-27 DE DE602004003751T patent/DE602004003751T2/de not_active Expired - Lifetime
- 2004-07-27 NO NO20043188A patent/NO327257B1/no not_active IP Right Cessation
- 2004-07-27 EA EA200400867A patent/EA007718B1/ru not_active IP Right Cessation
- 2004-07-27 SI SI200430167T patent/SI1502590T1/sl unknown
- 2004-07-27 MA MA27805A patent/MA27104A1/fr unknown
- 2004-07-27 NZ NZ534334A patent/NZ534334A/en not_active IP Right Cessation
- 2004-07-27 AR ARP040102657A patent/AR045125A1/es unknown
- 2004-07-27 DK DK04291901T patent/DK1502590T3/da active
- 2004-07-27 PT PT04291901T patent/PT1502590E/pt unknown
- 2004-07-27 EP EP04291901A patent/EP1502590B1/fr not_active Expired - Lifetime
- 2004-07-27 MX MXPA04007257A patent/MXPA04007257A/es active IP Right Grant
- 2004-07-28 KR KR1020040059237A patent/KR100677013B1/ko not_active Expired - Fee Related
- 2004-07-28 EG EG2004070320A patent/EG24967A/xx active
- 2004-07-28 JP JP2004219545A patent/JP4406331B2/ja not_active Expired - Fee Related
- 2004-07-28 AU AU2004203454A patent/AU2004203454B2/en not_active Ceased
- 2004-07-28 CN CNB2004100711283A patent/CN100497323C/zh not_active Expired - Fee Related
- 2004-07-29 US US10/902,345 patent/US7071221B2/en not_active Expired - Fee Related
2007
- 2007-02-22 CY CY20071100250T patent/CY1106336T1/el unknown
- 2007-03-20 HR HR20070117T patent/HRP20070117T8/xx unknown

Also Published As

Publication number	Publication date
JP4406331B2 (ja)	2010-01-27
CN100497323C (zh)	2009-06-10
EA007718B1 (ru)	2006-12-29
EP1502590B1 (fr)	2006-12-20
MXPA04007257A (es)	2005-03-31
PT1502590E (pt)	2007-02-28
ATE348612T1 (de)	2007-01-15
SI1502590T1 (sl)	2007-04-30
AU2004203454B2 (en)	2010-05-27
US7071221B2 (en)	2006-07-04
DE602004003751D1 (de)	2007-02-01
DK1502590T3 (da)	2007-04-10
CN1590379A (zh)	2005-03-09
BRPI0403028A (pt)	2005-06-14
KR100677013B1 (ko)	2007-01-31
HRP20070117T8 (en)	2007-07-31
FR2858321B1 (fr)	2006-01-20
NZ534334A (en)	2005-12-23
AR045125A1 (es)	2005-10-19
DE602004003751T2 (de)	2007-10-18
MY139278A (en)	2009-09-30
ZA200405893B (en)	2005-01-24
SG109010A1 (en)	2005-02-28
CA2475137C (fr)	2010-04-06
HRP20070117T3 (en)	2007-04-30
CA2475137A1 (fr)	2005-01-28
KR20050013514A (ko)	2005-02-04
CY1106336T1 (el)	2011-10-12
ES2279310T3 (es)	2007-08-16
NO327257B1 (no)	2009-05-25
JP2005047919A (ja)	2005-02-24
MA27104A1 (fr)	2004-12-20
AU2004203454A1 (en)	2005-02-17
EG24967A (en)	2011-03-13
EP1502590A1 (fr)	2005-02-02
EA200400867A2 (ru)	2005-02-24
US20050026973A1 (en)	2005-02-03
HK1071748A1 (zh)	2005-07-29
UA80814C2 (en)	2007-11-12
GEP20063896B (en)	2006-08-10
EA200400867A3 (ru)	2005-04-28
FR2858321A1 (fr)	2005-02-04
NO20043188L (no)	2005-01-31

Publication	Publication Date	Title
PL378168A1 (pl)	2006-03-06	Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
ZA200401948B (en)	2004-04-29	Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations.
TWI365866B (en)	2012-06-11	Amide derivatives, process for preparation thereof and use thereof as insecticide
IL163102A (en)	2011-07-31	Dihydrobenzodiazepin-2-one derivatives, process for their preparation and use thereof in the preparation of medicaments for the treatment of neurological disorders
NO20055204D0 (no)	2005-11-04	Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi
IL182624A0 (en)	2007-07-24	2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
ZA200700705B (en)	2008-06-25	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL178402A0 (en)	2007-02-11	1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
EP1515725A4 (en)	2005-09-21	USE OF CYCLOTHIOCARBAMATE DERIVATIVES IN THE TREATMENT OF HORMONE-RELATED ILLNESSES
IL180770A0 (en)	2007-06-03	Oxopiperidine derivatives, preparation and therapeutic use thereof
IL179424A0 (en)	2007-05-15	Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
ZA200700397B (en)	2007-11-28	Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
IL165395A0 (en)	2006-01-15	Use of thio-oxubdile derivatives in treatment of hormone-related conditions
SI1575951T1 (sl)	2014-10-30	Heterociklične spojine, postopki za njihovo izdelavo in njihova uporaba v terapiji
HRP20041157B1 (en)	2012-11-30	Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
IL180797A0 (en)	2007-06-03	Amino-tropane derivatives, preparation thereof and therapeutic use thereof
PL1502590T3 (pl)	2007-04-30	Pochodne oksymów heterocyklicznych, ich sposób wytwarzania i ich zastosowanie w leczeniu cukrzycy typu II
AU2003255612A8 (en)	2003-12-19	Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
IL177047A0 (en)	2006-12-10	Oxazole derivatives, preparation and therapeutic use thereof
EP1670894B8 (en)	2014-06-04	Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
NO20053809D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
TWI318211B (en)	2009-12-11	Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments
IL164248A0 (en)	2005-12-18	Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
PL1786759T3 (pl)	2012-11-30	Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
AU2003283574A1 (en)	2004-07-09	Process for the purification of hydroxyaryl-aldhydes and ketones and their use in the production of hydroxyaryl oxime derivatives